Literature DB >> 2266855

Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine.

A A Lindberg1, A Karnell, T Pál, H Sweiha, K Hultenby, B A Stocker.   

Abstract

A virulent Shigella flexneri serotype Y strain, SFL1, was made auxotrophic for aromatic metabolites, including p-aminobenzoic acid, which is not available in mammalian tissues, by transduction of a Tn10-inactivated aroD gene from Escherichia coli K-12 NK5131. One transductant, SFL114, selected for further studies, had the same biochemical and serological characteristics as the parent strain and the O-antigen patterns of the two strains were identical in SDS-PAGE and Western blot experiments. SFL114 was as invasive for cultured epithelial cells as SFL1, and both strains could escape from the phagocytic vacuole into the cytoplasm of the infected cells. However, the ability of SFL114 to multiply intracellularly was considerably reduced. When applied to the conjunctival sac of guinea pigs, the parent strain gave rise to keratoconjunctivitis, i.e. was Serény-positive, in 13 of 16 animals. By contrast, SFL114 was Serény-negative in all 11 guinea pigs tested. These in vitro and in vivo results suggest that the aromatic-dependent transductant S. flexneri SFL114 is attenuated and possesses properties desirable for a live vaccine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266855     DOI: 10.1016/0882-4010(90)90030-t

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  16 in total

1.  Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.

Authors:  S R Klee; B D Tzschaschel; I Fält; A Kärnell; A A Lindberg; K N Timmis; C A Guzmán
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo.

Authors:  A Fasano; F R Noriega; F M Liao; W Wang; M M Levine
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

3.  Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.

Authors:  K L Kotloff; F Noriega; G A Losonsky; M B Sztein; S S Wasserman; J P Nataro; M M Levine
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Serological cross-reaction between O-antigens of Shigella dysenteriae type 4 and an environmental Escherichia albertii isolate.

Authors:  Mohammed Ziaur Rahman; Selina Akter; Nafisa Azmuda; Munawar Sultana; François-Xavier Weill; Sirajul Islam Khan; Patrick A D Grimont; Nils-Kåre Birkeland
Journal:  Curr Microbiol       Date:  2013-06-09       Impact factor: 2.188

5.  Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.

Authors:  K L Kotloff; F R Noriega; T Samandari; M B Sztein; G A Losonsky; J P Nataro; W D Picking; E M Barry; M M Levine
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants.

Authors:  A Cersini; A M Salvia; M L Bernardini
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model.

Authors:  A B Hartman; M M Venkatesan
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.

Authors:  I C Fält; E K Schweda; S Klee; M Singh; E Floderus; K N Timmis; A A Lindberg
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490

9.  Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains.

Authors:  A B Hartman; C J Powell; C L Schultz; E V Oaks; K H Eckels
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

10.  A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.

Authors:  Petra C F Oyston; Gabriela Mellado-Sanchez; Marcela F Pasetti; James P Nataro; Richard W Titball; Helen S Atkins
Journal:  Microb Pathog       Date:  2010-01-22       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.